Sale!

EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the EIF2AK3 gene responsible for Wolcott-Rallison Syndrome. This rare autosomal recessive disorder typically presents with permanent neonatal or early-infancy diabetes mellitus, accompanied by skeletal abnormalities and episodic liver dysfunction. Using Next-Generation Sequencing (NGS) technology, this test provides precise detection of pathogenic variants with high accuracy. The test is particularly crucial for infants and young children showing symptoms of diabetes before six months of age, skeletal dysplasia, or recurrent liver dysfunction. Results help guide appropriate medical management, genetic counseling, and family planning decisions. The test is priced at $500 USD with genetic counseling included in the comprehensive package.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test

Comprehensive Genetic Analysis for Early-Onset Diabetes and Multi-Organ Disorders

The EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations in the EIF2AK3 gene, which encodes the eukaryotic translation initiation factor 2-alpha kinase 3. This specialized test is crucial for diagnosing Wolcott-Rallison Syndrome (WRS), a rare autosomal recessive disorder characterized by permanent neonatal or early-infancy diabetes mellitus, skeletal abnormalities, and episodic liver dysfunction. The test utilizes advanced Next-Generation Sequencing technology to provide comprehensive analysis of the entire EIF2AK3 gene with exceptional accuracy and reliability.

What This Advanced Genetic Test Detects

This sophisticated diagnostic test specifically identifies pathogenic variants in the EIF2AK3 gene, which plays a critical role in cellular stress response and protein synthesis regulation. The test detects:

  • Point mutations, insertions, and deletions in the EIF2AK3 gene
  • Autosomal recessive inheritance patterns
  • Mutations affecting the pancreatic beta-cell function
  • Genetic variants associated with endoplasmic reticulum stress response
  • Pathogenic changes impacting liver and skeletal development

Who Should Consider This Genetic Test

This comprehensive genetic analysis is recommended for individuals presenting with specific clinical features, particularly:

  • Infants and children with permanent diabetes mellitus developing before six months of age
  • Patients exhibiting skeletal dysplasia including epiphyseal dysplasia, osteoporosis, or growth retardation
  • Individuals with recurrent episodes of acute liver failure or hepatic dysfunction
  • Children showing developmental delay or neurological abnormalities
  • Families with consanguineous parents or previous affected siblings
  • Patients with unexplained multi-organ dysfunction involving pancreas, liver, and skeletal systems

Significant Benefits of EIF2AK3 Genetic Testing

Undergoing this specialized genetic test provides numerous advantages for patients and families:

  • Accurate Diagnosis: Provides definitive diagnosis of Wolcott-Rallison Syndrome, eliminating diagnostic uncertainty
  • Early Intervention: Enables prompt initiation of appropriate medical management for diabetes and liver complications
  • Family Planning Guidance: Offers crucial information for genetic counseling and reproductive decision-making
  • Comprehensive Care Planning: Helps develop targeted treatment strategies for multi-system involvement
  • Prognostic Information: Provides insights into disease progression and potential complications
  • Genetic Confirmation: Confirms clinical suspicions and guides appropriate specialist referrals

Understanding Your Test Results

Our comprehensive genetic counseling service helps you interpret your EIF2AK3 gene test results:

  • Positive Result: Indicates pathogenic mutations in both copies of the EIF2AK3 gene, confirming Wolcott-Rallison Syndrome diagnosis
  • Carrier Status: Identifies individuals with one mutated copy who are asymptomatic carriers
  • Negative Result: Suggests absence of detectable EIF2AK3 mutations, though clinical correlation remains essential
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation for interpretation

All results are accompanied by detailed genetic counseling to ensure complete understanding and appropriate next steps.

Test Pricing and Comprehensive Package

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We provide comprehensive genetic testing services across the United States with convenient locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let diagnostic uncertainty delay appropriate care. Our specialized genetic testing provides the answers you need for effective medical management and informed family planning decisions. With comprehensive genetic counseling included in your test package, you’ll receive expert guidance every step of the way.

Book your EIF2AK3 Gene Wolcott-Rallison Syndrome NGS Genetic DNA Test today by calling our dedicated genetic specialists at +1(267) 388-9828 or schedule your consultation through our secure online booking system.

Our team of certified genetic counselors and medical professionals is ready to provide the comprehensive support and expert interpretation you need for this important genetic analysis.